A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines.
about
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patientsA full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.Influence of synthetic superparamagnetic iron oxide on dendritic cells.Long-term storage of DNA-free RNA for use in vaccine studiesImmunotherapy of malignant brain tumors.Dendritic cell-based vaccines for the therapy of experimental tumors.Brain Tumor Immunotherapy: What have We Learned so Far?Improving vaccine efficacy against malignant gliomaEnhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer.Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells.A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells.The impact of electrical charge on the viability and physiology of dendritic cells.A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.
P2860
Q24651090-8B9ED063-DCC0-457F-92B8-E1708F1B2C93Q33289806-6ECEDF8D-4AD8-4619-9D0A-55B19B454245Q33595455-CE8A4728-2CAE-40B1-A735-6810D7AFE655Q34528054-DF7A60F2-8799-4C14-A9AF-10CFC519DE59Q35254464-11DD6C84-7ACE-4CEA-9277-7475AEB508D3Q35920469-44E1910D-40C1-4C12-BAA9-E63BEFA47776Q36162929-E3BEC5C9-7869-4C9F-A34E-50F54E51A66DQ37773259-CA153F7C-5DA0-4786-92BB-9AFC80B3A8D7Q38542113-C36957C7-8898-4098-9D78-85E82992BA14Q38953024-CF7A72F7-4012-4924-B61D-272DD9CABBEEQ40064005-864D66F1-EA4A-4278-855D-649C807AB758Q40508600-034EB316-29CC-4D65-9B21-E0406910C1FBQ41867724-8FCB5E9A-0E4B-4FEB-B6CF-0FE596112969Q46777207-77AFB9C2-EBA6-4127-81CC-A51F44E6E814Q51134700-F435773E-E0A8-4087-A8B1-0EA63C3A2A2E
P2860
A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A protocol for generation of c ...... tic cells for cancer vaccines.
@en
A protocol for generation of c ...... tic cells for cancer vaccines.
@nl
type
label
A protocol for generation of c ...... tic cells for cancer vaccines.
@en
A protocol for generation of c ...... tic cells for cancer vaccines.
@nl
prefLabel
A protocol for generation of c ...... tic cells for cancer vaccines.
@en
A protocol for generation of c ...... tic cells for cancer vaccines.
@nl
P2093
P2860
P1476
A protocol for generation of c ...... tic cells for cancer vaccines.
@en
P2093
Hammerstad H
Kvalheim G
Saebøe-Larssen S
P2860
P304
P356
10.1046/J.1365-3083.2003.01333.X
P577
2003-11-01T00:00:00Z